E. Pezzolo, “Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis)”, Acta Derm Venereol, vol. 106, pp. adv–2025, Apr. 2026.